Elevance Health Surges to 51st in Trading Volume with $1.074 Billion in Shares Exchanged

On June 6, 2025, Elevance Health (ELV) saw a significant surge in trading volume, with a total of $1.074 billion in shares exchanged, marking a 31.69% increase from the previous day. This surge placed Elevance Health at the 51st position in terms of trading volume for the day. The stock price of Elevance Health also rose by 2.26%, marking the fourth consecutive day of gains, with a total increase of 4.33% over the past four days.

Elevance Health is projected to experience a 36% growth in earnings per share (EPS) over the next three years, driven by the expansion of value-based care and the scaling of digital health platforms. This growth is expected to accelerate, with EPS projected to increase from $33.04 in 2024 to $45.06 by 2027. The company's integrated healthcare model, which combines health benefits with Carelon health services and advanced digital platforms, is at the forefront of transforming healthcare to be more affordable, accessible, and personalized.

Elevance Health's stock is currently trading at around $385 per share, which is below its historical valuations. Despite this, the company is leading the industry's transformation with innovative care delivery models. The 2-Minute Valuation Model values Elevance Health stock at $509 per share in two years, indicating a potential 32% upside from the current price. This valuation is based on a conservative approach, using a forward P/E multiple of 11x and an expected EPS of $45 in 2027.

Analysts have an average price target of around $510 per share for Elevance Health stock, indicating they see about 30% upside based on the current share price. However, investors should be aware of several risks that could impact Elevance Health's growth trajectory, including regulatory uncertainty, competition intensity, medical cost inflation, and technology execution.